New treatments for drug-resistant tuberculosis (TB) have brought hope to patients, but access to these medicines and their pricing have been simmering issues in some resource-constrained high-burden markets.
The TB Alliance has been moving at a fast clip sewing up alliances to ensure an affordable, sustainable and competitive...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
